Table 1. Comparison of rapid BYOSINEX COVID-19 BSS with the MAGLUMI 2019-nCoV for SARS-CoV-2 IgM and IgG detection.
MAGLUMI 2019-nCov | ||||
---|---|---|---|---|
SARS-CoV-2 IgM | Positive | Negative | Total | |
Positive | 24 (34%) | 5 (7%) | 29 (41%) | |
BIOSYNEX COVID-19 BSS | Negative | 5 (7%) | 36 (51%) | 41 (59%) |
Total | 29 (41%) | 41 (59%) | 70 (100%) | |
MAGLUMI 2019-nCov | ||||
SARS-CoV-2 IgG | Positive | Negative | Total | |
Positive | 36 (51%) | 2 (3%) | 38 (54%) | |
BIOSYNEX COVID-19 BSS | Negative | 8 (11%) | 24 (34%) | 32 (46%) |
Total | 44 (63%) | 26 (37%) | 70 (100%) |